Skip to main content
Figure 3 | BMC Cancer

Figure 3

From: Low expression of a few genes indicates good prognosis in estrogen receptor positive breast cancer

Figure 3

Kaplan-Meier survival plot for AP4 in the validation set. The validation set consists of the ER+ samples in the cohorts OXFD, GUYT, MZ and GUYT2, totalling 475 patients. The 5 and 10-year metastasis-free survival probabilities for the AP4- group are 0.95 (95% CI 0.92 – 0.98) and 0.89 (95% CI 0.85 – 0.93), respectively. The corresponding probabilities for the AP4+ group are 0.77 (95% CI 0.73 – 0.81) and 0.65 (95% CI 0.60 – 0.70). The hazard ratio between AP4+ and AP4- is 3.76 (95% CI 2.16 – 6.56).

Back to article page
\